HHT

Basel, Switzerland & Lincolnshire, Illinois, August,11, 2026 Vaderis Therapeutics, a clinical-stage biopharmaceutical company focused on targeted therapies for rare...

BRIDGEWATER, N.J., July 16, 2026 Insmed Incorporated has announced positive 12-month results from the ongoing open-label extension (OLE) study...

WATERTOWN, Mass., July 16, 2026 Diagonal Therapeutics has reached a significant milestone in rare disease drug development by announcing...